FITXR
23.3.2023 14:01:34 CET | Business Wire | Press release
FitXR is continuing to expand its popular virtual reality (VR) fitness offering with the UK, EU and Asia markets by launching on the popular PICO VR headsets. FitXR’s launch on PICO represents its commitment to make VR fitness accessible to all, irrespective of the user’s preference in hardware choice. As the mass market appeal in VR continues to grow, it will bring with it increased interest in hardware developers, innovation and consumer choice and in turn the desirability in multi-platform offerings like FitXR.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230323005314/en/
(Photo: Business Wire)
In January 2023, FitXR launched two new studio offerings: Sculpt and Combat, to add to its already robust suite of offerings that include High Intensity Interval Training (HIIT), Dance and Box workout options. The launch of Sculpt (workouts inspired by barre, pilates, and isometric strength training) and Combat (workouts inspired by karate, muay thai and taekwondo) support FitXR’s continued mission to provide the widest variety of workout experiences available in the metaverse today.
FitXR is now reaching new audiences by bringing its at-home virtual fitness experience to PICO headsets. Starting today, any consumer who downloads FitXR onto their PICO 4 or PICO Neo Link 3 headset will get 30 days free membership; an offer running until the 30th of April.
“Launching on PICO is a pivotal moment for FitXR,” said Sam Cole, CEO and Co-founder of FitXR. “We already offer the most diverse and unique fitness experience, and by expanding to the new PICO headset, we’re furthering our aim to provide this to every person, in every household, in every geography, and on any hardware device. It also reinforces our position as the leading global VR Fitness app with members around the world.”
“For PICO, launching FitXR as a subscription app on our platform underlines our commitment to bring the widest variety of high quality and customizable fitness experiences to our customers,” said Peter Li, Head of Gaming Partnerships at PICO.
FitXR’s launch on PICO is also indicative of the heightened appetite for combining technology and gaming to provide the optimal fitness experience. On FitXR, users can access different fitness studios whilst customising these experiences to meet their goals. Every time members enter the app, they can choose exactly how they want to work out; by studio type, music genre, intensity level, and/or time duration and then choose from one of many fully immersive 3D workout environments. Members can Dance or Box on a downtown city building rooftop, take Sculpt classes on the beachfront seaside or fight and defend in an outdoor martial arts-inspired Combat arena - all while punching flying fireballs, earning points and extending their winning streak.
“We never forget to bring the fun. The fun matters just as much as the results,” said Lisa Raggiri, Chief Marketing Officer at FitXR. “Whilst all of our classes are choreographed by certified fitness instructors to ensure results, we are strong believers in leveraging the unique immersive nature of VR to provide a fun escape. We know that by jumping into a fully immersive workout, our members have greater enjoyment, improve their consistency and see real results.”
In case variety, customization, gamification and numerous 3D environments wasn’t enough, FitXR is launching its first Box Training Program created in partnership with Olympic Boxing Champion Nicola Adams.
Says Nicola: “I am so excited to be able to finally share that I’ve been working closely alongside FitXR on this new boxing starter program, Box Like a Pro. We’ve broken it down and will delve into the principles of boxing – whether you’re looking to work on the perfect stance or refining your uppercut, this program is one for all. Regardless of your level, this program provides both beginners and intermediate boxers with the foundations and technical skills to build on and succeed. Having begun boxing at a young age, it’s been vital in helping build up my confidence and I hope users step away from this program feeling stronger and more energized, both mentally and physically. My hope is that I can inspire people to get more active, build and maintain a healthy lifestyle and show that fitness can be fun! I love spending weekends gaming, so I’ve enjoyed being able to blend it into fitness with FitXR. It’s been inspiring to partner with FitXR who have made transformative strides in elevating fitness for the better and making it more inclusive for all.”
About FitXR:
FitXR merges immersive VR with total body workouts designed by top fitness experts. Dedicated to making fitness more fun and accessible for everyone, FitXR offers classes within five distinct workout studios - Box, Dance, HIIT, Sculpt and Combat. FitXR provides a truly engaging, multiplayer experience along with constantly refreshed classes, environments and music. FitXR is available on Meta Quest 2.
About PICO:
Founded in March 2015, PICO is a leading VR company with independent innovation and R&D capabilities, focusing on VR all-in-one technology. Embracing a mission to bridge connections, enrich life, and release infinity, PICO is committed to building an integrated XR platform that inspires the community and empowers developers, creators, and businesses. To learn more, visit picoxr.com or business.picoxr.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230323005314/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
